Jazz Pharmaceuticals plc
JAZZ
$103.58
$5.805.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -92.54M | 191.12M | 215.06M | 168.57M | -14.62M |
| Total Depreciation and Amortization | 164.87M | 168.42M | 165.23M | 163.04M | 163.38M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 69.55M | 118.98M | 44.84M | 26.56M | 62.06M |
| Change in Net Operating Assets | 287.90M | -79.93M | -26.38M | -26.81M | 56.40M |
| Cash from Operations | 429.78M | 398.58M | 398.75M | 331.35M | 267.23M |
| Capital Expenditure | -13.88M | -13.29M | -10.79M | -7.09M | -6.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -155.05M | -180.00M | 224.88M | -250.00M | -265.00M |
| Cash from Investing | -168.93M | -193.29M | 214.09M | -257.09M | -271.90M |
| Total Debt Issued | -- | 0.00 | 980.77M | -- | -- |
| Total Debt Repaid | -757.75M | -7.75M | -582.75M | -7.75M | -7.75M |
| Issuance of Common Stock | 11.45M | 9.20M | 17.00K | 10.94M | 494.00K |
| Repurchase of Common Stock | -67.16M | -4.01M | -151.61M | -164.28M | -49.30M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -5.72M | -- | -- | -- |
| Cash from Financing | -813.47M | -8.28M | 246.43M | -161.09M | -56.55M |
| Foreign Exchange rate Adjustments | 1.70M | -2.29M | 3.07M | -759.00K | -1.70M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -550.92M | 194.73M | 862.33M | -87.58M | -62.93M |